Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03095274
Title Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin (DUNE)
Acronym DUNE
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol de Tumores Neuroendocrinos
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitario Marqués de Valdecilla Santander Asturias Spain Details
Instituto Catalán de Oncología Badalona Badalona Barcelona Spain Details
Complejo Hospitalario de Navarra Pamplona Navarra Spain Details
Hospital Duran i Reynals/ICO L'Hospitalet Barcelona Spain Details
Hospital Universitari Vall d'Hebron Barcelona Spain Details
Hospital Universitario de Burgos Burgos Spain Details
Hospital Universitario Donostia Donostia San Sebastian Spain Details
Hospital Universitario Virgen de las Nieves Granada Spain Details
Hospital Universitario 12 de Octubre Madrid Spain Details
Hospital Universitario Gregorio Marañón Madrid Spain Details
Hospital Universitario HM Sanchinarro Madrid Spain Details
Hospital Universitario La Paz Madrid Spain Details
Hospital Universitario Ramón y Cajal Madrid Spain Details
Hospital General Universitario Morales Meseguer Murcia Spain Details
Hospital Universitario Virgen de la Victoria Málaga Spain Details
Hospital Universitario de Canarias Santa Cruz de Tenerife Spain Details
Hospital Universitario Virgen del Rocío Sevilla Spain Details
Hospital Universitario y Politécnico La Fe Valencia Spain Details
Hospital Universitario Miguel Servet Zaragoza Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field